^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TSC-204-C0702

    i
    Associations
    News

    Trials

    Company:
    TSCan Therap
    Drug class:
    TCR modulator, MAGE-A1 modulator
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors (NCT05973487)
    Phase 1
    TScan Therapeutics, Inc.
    Recruiting
    Last update posted :
    06/14/2024
    Initiation :
    05/06/2024
    Primary completion :
    12/30/2026
    Completion :
    12/30/2026
    HLA-A • PRAME • HLA-C
    |
    HLA-A*02
    |
    T-Plex-200-A0201/204-A0201 • TSC-200-A0201 • TSC-204-A0201 • TSC-204-C0702